Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,171,863
  • Shares Outstanding, K 143,393
  • Annual Sales, $ 2,340 M
  • Annual Income, $ 315,590 K
  • 60-Month Beta 0.56
  • Price/Sales 6.95
  • Price/Cash Flow 25.79
  • Price/Book 8.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.92
  • Number of Estimates 3
  • High Estimate 0.97
  • Low Estimate 0.88
  • Prior Year 0.95
  • Growth Rate Est. (year over year) -3.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.81 +16.50%
on 04/18/19
114.90 -1.85%
on 05/03/19
+15.41 (+15.83%)
since 04/17/19
3-Month
96.81 +16.50%
on 04/18/19
114.90 -1.85%
on 05/03/19
+12.33 (+12.27%)
since 02/15/19
52-Week
90.64 +24.43%
on 01/29/19
118.50 -4.83%
on 01/18/19
+11.35 (+11.19%)
since 05/17/18

Most Recent Stories

More News
ResMed Elects Jan De Witte to Its Board of Directors

--Current CEO based in Europe brings valuable perspective to help guide ResMed's expanding global connected health businesses

RMD : 112.78 (-0.57%)
Here's Why You Should Hold on to ResMed (RMD) Stock for Now

ResMed (RMD) continues to see strong sales from SaaS business as well as new mask products and devices.

RMD : 112.78 (-0.57%)
MASI : 140.77 (-3.30%)
XRAY : 54.43 (-0.84%)
CNMD : 80.32 (-1.92%)
Brightree Announces Access to CommonWell Health Alliance Network for Home Health and Hospice Customers

--Enables Brightree customers to create a broader view of a patient's care by sharing information with more than 50,000 healthcare provider locations

RMD : 112.78 (-0.57%)
Relatively Good Performance Detected in Shares of Insulet Corp in the Health Care Equipment Industry (PODD , TNDM, RMD , GKOS , CSII )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

TNDM : 67.13 (-4.00%)
RMD : 112.78 (-0.57%)
PODD : 103.90 (-2.17%)
Resmed Inc Set to Possibly Pullback After Yesterday's Rally of 7.64%

Resmed Inc (NYSE:RMD) traded in a range yesterday that spanned from a low of $111.79 to a high of $113.82. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high of $105.64...

RMD : 112.78 (-0.57%)
ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line

ResMed (RMD) registers double-digit global revenue growth in Q3 on the back of solid sales from Software-as-a-Service businesses and new mask products plus devices.

ABT : 75.97 (-0.82%)
SYK : 184.14 (-0.80%)
RMD : 112.78 (-0.57%)
CNMD : 80.32 (-1.92%)
ResMed (RMD) Q3 Earnings Surpass Estimates

ResMed (RMD) delivered earnings and revenue surprises of 5.95% and -0.19%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RMD : 112.78 (-0.57%)
ResMed: Fiscal 3Q Earnings Snapshot

SAN DIEGO (AP) _ ResMed Inc. (RMD) on Thursday reported fiscal third-quarter net income of $105.4 million.

RSMDF : 10.4800 (+6.94%)
RMD : 112.78 (-0.57%)
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019

--MatrixCare contributes positively to revenue, gross margin, and profit

RMD : 112.78 (-0.57%)
Nevro Corp is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (NVRO , RMD , ATRC , EW , VAR )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 62.23 (-1.60%)
RMD : 112.78 (-0.57%)
ATRC : 29.42 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade RMD with:

Business Summary

ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions....

See More

Key Turning Points

2nd Resistance Point 115.05
1st Resistance Point 113.91
Last Price 112.78
1st Support Level 111.89
2nd Support Level 111.01

See More

52-Week High 118.50
Last Price 112.78
Fibonacci 61.8% 107.86
Fibonacci 50% 104.57
Fibonacci 38.2% 101.28
52-Week Low 90.64

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar